XRAY vs TFX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 17, 2026

XRAY

59.0
AI Score
VS
XRAY Wins

TFX

55.3
AI Score

Investment Advisor Scores

XRAY

59score
Recommendation
HOLD

TFX

55score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric XRAY TFX Winner
Forward P/E 8.2713 20.9644 XRAY
PEG Ratio 0.7521 0.1641 TFX
Revenue Growth -4.1% 28.9% TFX
Earnings Growth 15.2% -17.3% XRAY
Tradestie Score 59.0/100 55.3/100 XRAY
Profit Margin -15.0% -45.8% XRAY
Beta 1.00 1.00 Tie
AI Recommendation HOLD STRONG BUY TFX

Relative Price Performance (Last 90 Days)

XRAY 1M: -14.2% · 3M: +10.0% TFX 1M: +5.8% · 3M: +5.3%

Current Technical Phase

XRAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 36.2 · Price: $10.92

TFX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.5% over 20 days), RSI 57

RSI (14): 56.9 · Price: $138.83

Fundamentals Snapshot

Metric XRAY TFX
Market Cap
Forward P/E 7.2 12.3
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.3%
Gross Margin 0.5% 0.6%
Operating Margin 0.1% 0.1%
EPS -2.71 -0.54
Dividend Yield 0.03% 0.01%

Frequently Asked Questions

Based on our detailed analysis, XRAY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.